Quest Diagnostics Incorporated
DGX
Kedudukan dalam Saham
#929
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Harga Saham
$236.69
Modal Pasaran
$26.12B
Perubahan (1 hari)
0.80%
Perubahan (1 tahun)
24.31%
Negara
US
Perdagangan Quest Diagnostics Incorporated (DGX)
Kategori
Healthcare
Bilangan saham terbitan bagi Quest Diagnostics Incorporated (DGX)
Bilangan saham terbitan setakat June 2026: 110.00M
Menurut laporan kewangan terkini dan harga saham Quest Diagnostics Incorporated, bilangan saham terbitan semasa ialah 110.00M. Pada akhir December 2024, syarikat mempunyai 111.00M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Quest Diagnostics Incorporated (DGX) dari 2000 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 110.00M | -0.90% |
| 2025 | 111.00M | 0.00% |
| 2024 | 111.00M | -0.89% |
| 2023 | 112.00M | -3.45% |
| 2022 | 116.00M | -7.20% |
| 2021 | 125.00M | -6.72% |
| 2020 | 134.00M | 0.00% |
| 2019 | 134.00M | -1.47% |
| 2018 | 136.00M | -0.73% |
| 2017 | 137.00M | -2.14% |
| 2016 | 140.00M | -2.78% |
| 2015 | 144.00M | -0.69% |
| 2014 | 145.00M | -4.61% |
| 2013 | 152.00M | -4.16% |
| 2012 | 158.60M | -0.06% |
| 2011 | 158.70M | -9.68% |
| 2010 | 175.70M | -5.49% |
| 2009 | 185.90M | -4.32% |
| 2008 | 194.30M | 0.55% |
| 2007 | 193.24M | -1.90% |
| 2006 | 196.99M | -2.40% |
| 2005 | 201.83M | -0.94% |
| 2004 | 203.75M | -1.56% |
| 2003 | 206.97M | 7.29% |
| 2002 | 192.91M | 3.40% |
| 2001 | 186.56M | 4.20% |
| 2000 | 179.04M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 371.00M | 237.27% |
US
|
|
| 705.30M | 541.18% |
US
|
|
| 143.28M | 30.25% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 156.36% |
US
|
